United States Active Pharmaceutical Ingredient Industry 2016 Market Research Report

Publisher Name :
Date: 19-Sep-2016
No. of pages: 130
Inquire Before Buying

The United States Active Pharmaceutical Ingredient Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Active Pharmaceutical Ingredient industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Active Pharmaceutical Ingredient market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Active Pharmaceutical Ingredient industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 150 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

United States Active Pharmaceutical Ingredient Industry 2016 Market Research Report

Table of Contents
1 Industry Overview
1.1 Definition and Specifications of Active Pharmaceutical Ingredient
1.2 Classification of Active Pharmaceutical Ingredient
1.3 Applications of Active Pharmaceutical Ingredient
1.4 Industry Chain Structure of Active Pharmaceutical Ingredient
1.5 Industry Overview of Active Pharmaceutical Ingredient
1.6 Industry Policy Analysis of Active Pharmaceutical Ingredient
1.7 Industry News Analysis of Active Pharmaceutical Ingredient
2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient
2.1 Bill of Materials (BOM) of Active Pharmaceutical Ingredient
2.2 BOM Price Analysis of Active Pharmaceutical Ingredient
2.3 Labor Cost Analysis of Active Pharmaceutical Ingredient
2.4 Depreciation Cost Analysis of Active Pharmaceutical Ingredient
2.5 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient
2.6 Manufacturing Process Analysis of Active Pharmaceutical Ingredient
2.7 United States Price, Cost and Gross of Active Pharmaceutical Ingredient 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Active Pharmaceutical Ingredient Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Active Pharmaceutical Ingredient Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Active Pharmaceutical Ingredient Key Manufacturers in 2015
4 Production Analysis of Active Pharmaceutical Ingredient by Regions, Type, and Applications
4.1 United States Production of Active Pharmaceutical Ingredient by Regions 2011-2016
4.2 United States Production of Active Pharmaceutical Ingredient by Type 2011-2016
4.3 United States Sales of Active Pharmaceutical Ingredient by Applications 2011-2016
4.4 Price Analysis of United States Active Pharmaceutical Ingredient Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Active Pharmaceutical Ingredient 2011-2016
5 Consumption Volume and Consumption Value Analysis of Active Pharmaceutical Ingredient by Regions
5.1 United States Consumption Volume of Active Pharmaceutical Ingredient by Regions 2011-2016
5.2 United States Consumption Value of Active Pharmaceutical Ingredient by Regions 2011-2016
5.3 United States Consumption Price Analysis of Active Pharmaceutical Ingredient by Regions 2011-2016
6 Analysis of Active Pharmaceutical Ingredient Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Active Pharmaceutical Ingredient 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Active Pharmaceutical Ingredient 2014-2015
6.3 Sales Overview of Active Pharmaceutical Ingredient 2011-2016
6.4 Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2011-2016
6.5 Import, Export and Consumption of Active Pharmaceutical Ingredient 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Active Pharmaceutical Ingredient 2011-2016
7 Analysis of Active Pharmaceutical Ingredient Industry Key Manufacturers
7.1 Albemarle Corporation
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Albemarle Corporation SWOT Analysis
7.2 Allergan Plc
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Allergan Plc SWOT Analysis
7.3 Aurobindo Pharma Ltd.
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Aurobindo Pharma Ltd. SWOT Analysis
7.4 Boehringer Ingelheim
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Boehringer Ingelheim SWOT Analysis
7.5 Dr. Reddy'S Laboratories Ltd.
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Dr. Reddy'S Laboratories Ltd. SWOT Analysis
7.6 Mylan Inc.
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Mylan Inc. SWOT Analysis
7.7 Novartis International Ag
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Novartis International Ag SWOT Analysis
7.8 Sigma-Aldrich Corporation
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Sigma-Aldrich Corporation SWOT Analysis
7.9 Sun Pharmaceutical Industries Ltd.
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Sun Pharmaceutical Industries Ltd. SWOT Analysis
7.10 Teva Pharmaceutical Industries Limited
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Teva Pharmaceutical Industries Limited SWOT Analysis
7.11 Ranbaxy
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Ranbaxy SWOT Analysis
7.12 Covidien
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Covidien SWOT Analysis
7.13 Lupin
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Lupin SWOT Analysis
7.14 Lonza
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Lonza SWOT Analysis
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Active Pharmaceutical Ingredient Product Types
8.5 Market Share Analysis of Different Active Pharmaceutical Ingredient Price Levels
8.6 Gross Margin Analysis of Different Active Pharmaceutical Ingredient Applications
9 Marketing Trader or Distributor Analysis of Active Pharmaceutical Ingredient
9.1 Marketing Channels Status of Active Pharmaceutical Ingredient
9.2 Traders or Distributors of Active Pharmaceutical Ingredient with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Active Pharmaceutical Ingredient
9.4 United States Import, Export and Trade Analysis of Active Pharmaceutical Ingredient
10 Development Trend of Active Pharmaceutical Ingredient Industry 2016-2021
10.1 Capacity and Production Overview of Active Pharmaceutical Ingredient 2016-2021
10.2 Production Market Share by Product Types of Active Pharmaceutical Ingredient 2016-2021
10.3 Sales and Sales Revenue Overview of Active Pharmaceutical Ingredient 2016-2021
10.4 United States Sales of Active Pharmaceutical Ingredient by Applications 2016-2021
10.5 Import, Export and Consumption of Active Pharmaceutical Ingredient 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Active Pharmaceutical Ingredient 2016-2021
11 Industry Chain Suppliers of Active Pharmaceutical Ingredient with Contact Information
11.1 Major Raw Materials Suppliers of Active Pharmaceutical Ingredient with Contact Information
11.2 Manufacturing Equipment Suppliers of Active Pharmaceutical Ingredient with Contact Information
11.3 Major Players of Active Pharmaceutical Ingredient with Contact Information
11.4 Key Consumers of Active Pharmaceutical Ingredient with Contact Information
11.5 Supply Chain Relationship Analysis of Active Pharmaceutical Ingredient
12 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredient
12.1 New Project SWOT Analysis of Active Pharmaceutical Ingredient
12.2 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredient
13 Conclusion of the United States Active Pharmaceutical Ingredient Industry 2016 Market Research Report
List of Tables and Figures
Figure Picture of Active Pharmaceutical Ingredient
Table Product Specifications of Active Pharmaceutical Ingredient
Table Classification of Active Pharmaceutical Ingredient
Figure United States Sales Market Share of Active Pharmaceutical Ingredient by Product Types in 2015
Table Applications of Active Pharmaceutical Ingredient
Figure United States Sales Market Share of Active Pharmaceutical Ingredient by Applications in 2015
Figure Industry Chain Structure of Active Pharmaceutical Ingredient
Table United States Industry Overview of Active Pharmaceutical Ingredient
Table Industry Policy of Active Pharmaceutical Ingredient
Table Industry News List of Active Pharmaceutical Ingredient
Table Bill of Materials (BOM) of Active Pharmaceutical Ingredient
Table Bill of Materials (BOM) Price of Active Pharmaceutical Ingredient
Table Labor Cost of Active Pharmaceutical Ingredient
Table Depreciation Cost of Active Pharmaceutical Ingredient
Table Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient in 2015
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredient
Table United States Price Analysis of Active Pharmaceutical Ingredient 2011-2016 (USD/Unit)
Table United States Cost Analysis of Active Pharmaceutical Ingredient 2011-2016 (USD/Unit)
Table United States Gross Analysis of Active Pharmaceutical Ingredient 2011-2016
Table Capacity (K Units) and Commercial Production Date of United States Active Pharmaceutical Ingredient Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Active Pharmaceutical Ingredient Manufacturers in 2015
Table R&D Status and Technology Source of United States Active Pharmaceutical Ingredient Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Active Pharmaceutical Ingredient Key Manufacturers in 2015
Table United States Production of Active Pharmaceutical Ingredient by Regions 2011-2016 (K Units)
Table United States Production Market Share of Active Pharmaceutical Ingredient by Regions 2011-2016
Figure United States Production Market Share of Active Pharmaceutical Ingredient by Regions in 2014
Figure United States Production Market Share of Active Pharmaceutical Ingredient by Regions in 2015
Table United States Production of Active Pharmaceutical Ingredient by Types in 2011-2016 (K Units)
Table United States Production Market Share of Active Pharmaceutical Ingredient by Type in 2011-2016
Figure United States Production Market Share of Active Pharmaceutical Ingredient by Type in 2014
Figure United States Production Market Share of Active Pharmaceutical Ingredient by Type in 2015
Table United States Sales of Active Pharmaceutical Ingredient by Applications 2011-2016 (K Units)
Table United States Production Market Share of Active Pharmaceutical Ingredient by Applications 2011-2016
Figure United States Production Market Share of Active Pharmaceutical Ingredient by Applications in 2014
Figure United States Production Market Share of Active Pharmaceutical Ingredient by Applications in 2015
Table Price Comparison of United States Active Pharmaceutical Ingredient Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Active Pharmaceutical Ingredient 2011-2016
Table United States Consumption Volume of Active Pharmaceutical Ingredient by Regions 2011-2016 (K Units)
Table United States Consumption Volume Market Share of Active Pharmaceutical Ingredient by Regions 2011-2016
Figure United States Consumption Volume Market Share of Active Pharmaceutical Ingredient by Regions in 2014
Figure United States Consumption Volume Market Share of Active Pharmaceutical Ingredient by Regions in 2015
Table United States Consumption Value of Active Pharmaceutical Ingredient by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Active Pharmaceutical Ingredient by Regions 2011-2016
Figure United States Consumption Value Market Share of Active Pharmaceutical Ingredient by Regions in 2014
Figure United States Consumption Value Market Share of Active Pharmaceutical Ingredient by Regions in 2015
Table Consumption Price of Active Pharmaceutical Ingredient by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Active Pharmaceutical Ingredient 2011-2016 (K Units)
Table United States Capacity Market Share of Major Active Pharmaceutical Ingredient Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Active Pharmaceutical Ingredient 2011-2016 (K Units)
Table United States Production Market Share of Major Active Pharmaceutical Ingredient Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Active Pharmaceutical Ingredient 2011-2016 (K Units)
Table United States Sales Market Share of Major Active Pharmaceutical Ingredient Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Active Pharmaceutical Ingredient 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Active Pharmaceutical Ingredient Manufacturers 2011-2016
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016
Figure United States Capacity Utilization Rate of Active Pharmaceutical Ingredient 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016
Figure United States Production Market Share of Major Active Pharmaceutical Ingredient Manufacturers in 2014
Figure United States Production Market Share of Major Active Pharmaceutical Ingredient Manufacturers in 2015
Figure United States Sales Market Share of Major Active Pharmaceutical Ingredient Manufacturers in 2014
Figure United States Sales Market Share of Major Active Pharmaceutical Ingredient Manufacturers in 2015
Figure United States Sales (K Units) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016
Table United States Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2011-2016 (K Units)
Table United States Import, Export and Consumption of Active Pharmaceutical Ingredient 2011-2016 (K Units)
Table Price of United States Active Pharmaceutical Ingredient Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Active Pharmaceutical Ingredient Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Active Pharmaceutical Ingredient 2011-2016 (M USD)
Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Active Pharmaceutical Ingredient 2011-2016
Table Albemarle Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Albemarle Corporation
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Albemarle Corporation 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Albemarle Corporation 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Albemarle Corporation 2011-2016
Table Albemarle Corporation Active Pharmaceutical Ingredient SWOT Analysis
Table Allergan Plc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Allergan Plc
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Allergan Plc 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Allergan Plc 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Allergan Plc 2011-2016
Table Allergan Plc Active Pharmaceutical Ingredient SWOT Analysis
Table Aurobindo Pharma Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Aurobindo Pharma Ltd.
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aurobindo Pharma Ltd. 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Aurobindo Pharma Ltd. 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Aurobindo Pharma Ltd. 2011-2016
Table Aurobindo Pharma Ltd. Active Pharmaceutical Ingredient SWOT Analysis
Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Boehringer Ingelheim
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Boehringer Ingelheim 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Boehringer Ingelheim 2011-2016
Table Boehringer Ingelheim Active Pharmaceutical Ingredient SWOT Analysis
Table Dr. Reddy'S Laboratories Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Dr. Reddy'S Laboratories Ltd.
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Dr. Reddy'S Laboratories Ltd. 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Dr. Reddy'S Laboratories Ltd. 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Dr. Reddy'S Laboratories Ltd. 2011-2016
Table Dr. Reddy'S Laboratories Ltd. Active Pharmaceutical Ingredient SWOT Analysis
Table Mylan Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Mylan Inc.
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mylan Inc. 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Mylan Inc. 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Mylan Inc. 2011-2016
Table Mylan Inc. Active Pharmaceutical Ingredient SWOT Analysis
Table Novartis International Ag Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Novartis International Ag
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis International Ag 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Novartis International Ag 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Novartis International Ag 2011-2016
Table Novartis International Ag Active Pharmaceutical Ingredient SWOT Analysis
Table Sigma-Aldrich Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Sigma-Aldrich Corporation
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sigma-Aldrich Corporation 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Sigma-Aldrich Corporation 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Sigma-Aldrich Corporation 2011-2016
Table Sigma-Aldrich Corporation Active Pharmaceutical Ingredient SWOT Analysis
Table Sun Pharmaceutical Industries Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Sun Pharmaceutical Industries Ltd.
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharmaceutical Industries Ltd. 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Sun Pharmaceutical Industries Ltd. 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Sun Pharmaceutical Industries Ltd. 2011-2016
Table Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient SWOT Analysis
Table Teva Pharmaceutical Industries Limited Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Teva Pharmaceutical Industries Limited
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries Limited 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Teva Pharmaceutical Industries Limited 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Teva Pharmaceutical Industries Limited 2011-2016
Table Teva Pharmaceutical Industries Limited Active Pharmaceutical Ingredient SWOT Analysis
Table Ranbaxy Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Ranbaxy
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ranbaxy 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Ranbaxy 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Ranbaxy 2011-2016
Table Ranbaxy Active Pharmaceutical Ingredient SWOT Analysis
Table Covidien Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Covidien
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Covidien 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Covidien 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Covidien 2011-2016
Table Covidien Active Pharmaceutical Ingredient SWOT Analysis
Table Lupin Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Lupin
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Lupin 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Lupin 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Lupin 2011-2016
Table Lupin Active Pharmaceutical Ingredient SWOT Analysis
Table Lonza Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredient Picture and Specifications of Lonza
Table Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Lonza 2011-2016
Figure Active Pharmaceutical Ingredient Capacity (K Units), Production (K Units) and Growth Rate of Lonza 2011-2016
Figure Active Pharmaceutical Ingredient Production (K Units) and United States Market Share of Lonza 2011-2016
Table Lonza Active Pharmaceutical Ingredient SWOT Analysis
Table Active Pharmaceutical Ingredient Price by Regions 2011-2016
Table Active Pharmaceutical Ingredient Price by Product Types 2011-2016
Table Active Pharmaceutical Ingredient Price by Companies 2011-2016
Table Active Pharmaceutical Ingredient Gross Margin by Companies 2011-2016
Table Price Comparison of Active Pharmaceutical Ingredient by Regions 2011-2016 (USD/Unit)
Table Price of Different Active Pharmaceutical Ingredient Product Types (USD/Unit)
Table Market Share of Different Active Pharmaceutical Ingredient Price Level
Table Gross Margin of Different Active Pharmaceutical Ingredient Applications
Table Marketing Channels Status of Active Pharmaceutical Ingredient
Table Traders or Distributors of Active Pharmaceutical Ingredient with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Active Pharmaceutical Ingredient (USD/Unit) in 2015
Table United States Import, Export, and Trade of Active Pharmaceutical Ingredient (K Units)
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021
Figure United States Capacity Utilization Rate of Active Pharmaceutical Ingredient 2016-2021
Table United States Active Pharmaceutical Ingredient Production by Type 2016-2021 (K Units)
Table United States Active Pharmaceutical Ingredient Production Market Share by Type 2016-2021
Figure United States Production Market Share of Active Pharmaceutical Ingredient by Type in 2021
Figure United States Sales (K Units) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021
Figure United States Sales of Active Pharmaceutical Ingredient by Applications 2016-2021 (K Units)
Table United States Production Market Share of Active Pharmaceutical Ingredient by Applications 2016-2021
Figure United States Production Market Share of Active Pharmaceutical Ingredient by Applications in 2021
Table United States Production, Import, Export and Consumption of Active Pharmaceutical Ingredient 2016-2021 (K Units)
Table United States Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Active Pharmaceutical Ingredient 2016-2021
Table Major Raw Materials Suppliers of Active Pharmaceutical Ingredient with Contact Information
Table Manufacturing Equipment Suppliers of Active Pharmaceutical Ingredient with Contact Information
Table Major Players of Active Pharmaceutical Ingredient with Contact Information
Table Key Consumers of Active Pharmaceutical Ingredient with Contact Information
Table Supply Chain Relationship Analysis of Active Pharmaceutical Ingredient
Table New Project SWOT Analysis of Active Pharmaceutical Ingredient
Table New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredient
Table Part of Interviewees Record List
  • 2017-2022 Perphenazine Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 16-Aug-2017        Price: US 2960 Onwards        Pages: 111
    This report studies the Perphenazine market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Perphenazine market by product type and applications/end industries. The global Perphenazine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and ......
  • 2017-2022 Sex Hormones and Birth Control Pills Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 16-Aug-2017        Price: US 2960 Onwards        Pages: 106
    This report studies the Sex Hormones and Birth Control Pills market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Sex Hormones and Birth Control Pills market by product type and applications/end industries. The global Sex Hormones and Birth Control Pills market is valued at XX million USD in 2016 and is expected to reach XX mi......
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 72
    C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2017, outlays comprehensive info......
  • C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 59
    C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - CXCR2 or Interleukin 8 receptor, beta is a chemokine receptor. It binds to IL8 with high affinity, and transduces the signal through a G-prot......
  • C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 54
    C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017, outlays comprehensive information on the C5a Anaphylato......
  • Global Human Herpersvirus 5 (HHV-5) Drug Market Size, Status and Forecast 2022
    Published: 16-Aug-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global Human Herpersvirus 5 (HHV-5) Drug market, analyzes and researches the Human Herpersvirus 5 (HHV-5) Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Roche - Livzon Pharmaceuticals - Sichuan Cologne Pharmaceutical - Hubei Branch benefits medicine - GlaxoSmithKline - Upright and clear - Chongqing Winbond (ac......
  • Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 53
    Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Prostaglandin D2 (PGD2) receptors are G protein-coupled receptors that binds and is activated by prostaglandin D2. ......
  • Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 45
    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017 Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. ......
  • Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 74
    Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017 Summary Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) pipeline Target constitutes close to 17 molecules. Out of which approximately 17 molecules are developed by Companies. The lat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs